Penserra Capital Management LLC - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$9,000
-35.7%
6,405
+72.0%
0.00%
Q1 2022$14,000
-48.1%
3,724
+6.8%
0.00%
-100.0%
Q4 2021$27,0003,4860.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$294,0000.05%
Shaolin Capital Management LLC 275,000$1,034,0000.03%
Spectrum Management Group, LLC 5,030$19,0000.00%
Veritable, L.P. 43,551$164,0000.00%
ALPS ADVISORS INC 45,083$170,0000.00%
ETF MANAGERS GROUP, LLC 13,187$34,0000.00%
Qube Research & Technologies Ltd 24,179$91,0000.00%
NORTHERN TRUST CORP 44,476$167,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 301,110$1,132,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders